Abstract
Background Building research capacity of European Society of Clinical Pharmacy (ESCP) members aligns to the organisation’s aim of advancing research. Objective To determine members’ aspirations and needs in research training and practice, and to explore ways in which ESCP could provide support. Setting ESCP’s international membership. Method Cross-sectional survey of members in 2018, followed by focus groups with samples of respondents attending an ESCP symposium. Survey items were: research activities; interests, experience and confidence; and Likert statements on research conduct. Principal component analysis (PCA) clustering of Likert statements from a previous study was used, with scores for each component calculated. Focus groups discussed barriers to research and how ESCP could provide support. Data analysis involved collating and comparing all themes. Main outcome measures Research interest, experience and confidence; attitudinal items; barriers to research; ESCP support. Results The response rate was 16.7% (83/499), with 89.2% (n = 74) involved in research and 79.5% (n = 66) publishing research in the preceding 2 years. While overwhelmingly positive, responses were more positive for research interest than experience or confidence. PCA component scores (support/opportunities, motivation/outcomes, and roles/characteristics) were positive. Thirteen members participated in focus groups, identifying barriers of: insufficient collaboration; lack of knowledge, skills, training; unsupportive environment; insufficient time; and limited resources. ESCP could support through mentorship, collaboration, education and funding. Conclusion Study participants were highly active, interested, experienced, confident and positive regarding research. There is an opportunity for ESCP to harness these activities and provide support in the form of mentoring, education and training, and facilitating collaboration.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Impacts on practice
-
There is an opportunity for ESCP to harness the research activities, interest, experience, confidence and generally positive views to create greater impact for patients, professionals, organisations and society across Europe and beyond.
-
ESCP as an organisation can provide support in the form of mentoring, education and training, focusing most on those form non-academic settings.
Introduction
Pharmacy practice is continually evolving, with pharmacists providing enhanced services involving direct patient care, such as general practice-based activities, non-medical prescribing, and specialist roles in ambulatory, secondary and tertiary care [1,2,3,4]. Consequently, the application of evidence-based practice (EBP), the integration of best available evidence with practitioners’ clinical expertise and patients’ values [5], is highly relevant. Awareness of, and participation in, research could facilitate adoption of EBP within current and emerging roles.
Professional organisations and regulatory bodies are placing increasing emphasis on participation in research. For example, the International Pharmaceutical Federation (FIP) emphasises the need for pharmacists to take on significant responsibilities in research in order to contribute to improvements in global health by advancing drug discovery and development, clinical practice and education [6].
However, limited published research exists on pharmacists’ current involvement in research and their future needs. Current available literature is mostly based in either the UK or non-European countries [7, 8]. In addition, there is a lack of consistent application of how research involvement or engagement has been defined and adopted. The existing published literature, albeit limited, suggests that barriers to participation and involvement are often behavioural in nature. For example, barriers include a lack of knowledge, skills and self-motivation. There is therefore a need to incorporate behaviour change theories or frameworks in undertaking future research in the area. Incorporation of behaviour change theory permits the identification of possible theoretical mechanisms of behaviour change leading to the development of targeted intervention(s) [9]. The Theoretical Domains Framework (TDF) includes constructs from 33 behaviour change theories, described in 14 domains (i.e. the determinants of behaviour) of: knowledge; skills; social/professional role and identity; beliefs about capabilities; optimism; beliefs about consequences; reinforcement; intentions; goals; memory, attention and decision processes; environmental context and resources; social influences; emotions; and behavioural regulation.
The use of the TDF has previously enabled assessment of associated barriers of pharmacists’ involvement in research, in diverse practice settings in Scotland [8]. Key barriers mapped to TDF domains of ‘knowledge’ (e.g. organization research priorities, training and funding opportunities), and ‘environmental context and resources’ (e.g. research active environment, time, support). Study limitations included the low response rate and absence of a qualitative phase to allow in-depth exploration of survey findings.
The European Society of Clinical Pharmacy (ESCP) is a professional network of clinical pharmacists in Europe. Established in 1979, ESCP aims to ‘promote, support, implement and advance education, practice and research in clinical pharmacy in order to optimise outcomes for patients and society’ [10]. Building research capacity, defined as ‘enhancing the abilities of individuals, organisations and systems to undertake and disseminate high quality research effectively and efficiently’ [11], aligns to this aim. There is an opportunity to engage with this network to identify the needs and future requirement of pharmacists in order to harness pharmacy practice research capacity and activities across Europe.
Aim of the study
Aims of the study were to determine ESCP members’ aspirations and needs in relation to research training and practice and to explore ways in which ESCP could support members in meeting these needs.
Ethics approval
The ESCP General Committee approved the study; as participants were members of an international organisation, there was no need for ethical review.
Method
Design
This was an explanatory, sequential mixed methods study involving a cross-sectional survey followed by a qualitative phase.
Cross-sectional survey
Inclusion and exclusion criteria
All ESCP members were invited to participate, excluding members of the ESCP Research Committee (n = 8), giving a study population of 499.
Questionnaire development
The questionnaire was based on that used in Scotland [8], adapted for the ESCP context. Items were based on the 14 domains of the TDF and the Transtheoretical Model of Behaviour Change [12]. Stages of change are ‘pre-contemplation’ (not ready), ‘contemplation’ (getting ready), ‘preparation’ (ready), ‘action’ and ‘maintenance’. In the demographics section, respondents classified themselves as innovators, early adopters, early majority, late majority and laggards based on receptivity to change, using the wording described by Rogers [13].
The questionnaire was tested for face and content validity by the members of the ESCP Research Committee. Given the previous use of a similar questionnaire [8], no pilot stage was conducted. The questionnaire was developed in Bristol Online Survey© and tested for compatibility with platforms (PC, tablet, smartphone), browsers and internet filters. Question types were a combination of closed and open questions to allow respondents to provide comments. Evidence-based strategies were employed to maximise the response rate [14], including: an information leaflet outlining the study aim and potential benefits; assuring anonymity; an attractive questionnaire; and two follow-up email reminders.
Data collection
During September 2018, ESCP members were sent an email from the ESCP International Office with a direct link to the information leaflet and questionnaire. Two email reminders were sent to all ESCP members at approximately 2-monthly intervals.
Analysis
The survey instrument generated data that were exported to Statistical Package for Social Sciences (SPSS Inc., Cary, NC version 25.0). Descriptive analysis was undertaken for: demographics; research activities; research interest, experience and confidence; views on research conduct; and readiness to participate in research and research training. Internal consistencies of responses on interest, experience and confidence were tested using Cronbach’s alpha, aiming for values ≥ 0.7 [15]. Total scores [median and interquartile range (IQR)] for each scale were obtained by assigning values (1 = no to 5 = very). Differences in total scores of interest, experience and confidence were tested using Friedman’s two-way analysis of variance by ranks. Correlation between overall scores of interest/experience, interest/confidence and experience/confidence were assessed using Spearman’s rho. P values ≤ 0.05 were considered to be statistically significant. Given the number of responses, it was not possible to conduct any inferential statistical analysis to investigate any differences between subgroups (e.g. age etc.)
While it was intended to use principal component analysis (PCA) to reduce the large number of TDF-related items to a smaller number of components [16], the number of responses proved insufficient. Consequently, the PCA components identified in the study in Scotland [8], were used to group the items into: support and opportunities to be involved in research; motivation for and outcomes of involvement in research; and individual roles and characteristics around involvement in research. Following determination of internal consistencies for each of the three components, total scores (median and interquartile range, IQR) were obtained by assigning scores of 1 (strongly disagree) to 5 (strongly agree) to each of the Likert statement responses and each of these compared to the scale midpoint.
Summative content analysis was independently performed by two members of the research team on the responses to the open questions, looking for patterns, similarities and differences [17].
ESCP symposium focus group
Recruitment
The focus group discussion took place at the ESCP Symposium in October 2018. Those attending the symposium who had completed the questionnaire were invited to participate. The session was of 1-h duration and moderated by three ESCP Research Committee members.
Data generation and analysis
Participants were arranged into groups, with data generated in two separate stages. In Stage 1, each participant was asked to individually record the top three barriers to fulfilling their research aspirations. These were recorded on post-it notes, which were then arranged into thematic groupings on a flip chart by group members. In Stage 2, groups discussed how ESCP could facilitate their research aspirations, being cognisant of the limited resources of ESCP. Each group recorded the outcomes of their discussion on flip charts as in Stage 1. Data analysis was independently undertaken by two researchers, involving collating, comparing and contrasting all themes.
Results
Cross-sectional survey
Demographics
Eighty-three responses were received, giving a response rate of 16.7%. Personal and practice demographics are shown in Table 1. Respondents were from a range of largely European countries, mainly Switzerland (13.3%, n = 11), Netherlands (10.8%, n = 9), Norway (7.2%, n = 6) and the UK (7.2%, n = 6). The majority had been ESCP members for ≤ 5 years (55.4%, n = 46), were aged < 50 years (71.1%, n = 59) and male (65.1%, n = 54). Just under half were working in academia (42.2%, n = 35), had worked > 15 years (47.0%, n = 39) and the majority were working full-time (81.9%, n = 68). Respondents were highly qualified with more than half possessing a Ph.D. (68.7%, n = 57). In terms of receptivity to change, almost three quarters (72.3%, n = 70) classified themselves as innovators and early adopters.
Research involvement
Over the preceding 2 years, 89.2% (n = 74) had been involved in research, 51.8% (n = 43) as principal investigator and 54.2% (n = 45) as co-investigator. The majority (79.5%, n = 66) had published research, 45.8% (n = 38) as corresponding author and 59.0% (n = 49) as co-author. Three quarters (74.7%, n = 62) had presented research at an international conference and around two-fifths (38.6%, n = 32) had supervised doctoral students.
Research interest, experience and confidence
Responses to items on interest, experience and confidence are reported in Table 2. The Cronbach’s alpha values for the items on interest, experience and confidence were 0.91, 0.96 and 0.95 respectively, indicating internal reliability. The median summary score (range possible 16–80, scale mid-point 48; high scores positive) for research interest was 68 (IQR 59–73), research experience 62 (IQR 53–70) and research confidence 64 (IQR 56–70). Summary scores for interest were significantly higher than confidence which were significantly higher than experience (χ2, P < 0.001). There were positive correlations between total scores for interest and experience, interest and confidence, and confidence and experience (Spearman’s rho, P < 0.001), with those more interested also more experienced and confident. The most negative responses were for items on: interest in conducting a systematic review, 42.1% (n = 35) reported no/little/some interest; experience in conducting a systematic review, 59.1% (n = 49) reported no/little/some experience; confidence in conducting a systematic review, 49.4% (n = 41) reported no/little/some confidence; and confidence in analysing and interpreting qualitative results, 47.0% (n = 39) reported no/little/some confidence.
Research involvement
Attitudinal statements were grouped into three components as per the previous study [8], labelled: support and opportunities to participate in research (Cronbach’s alpha 0.90); motivation for and outcomes of participation in research (Cronbach’s alpha 0.896); and individual roles and characteristics around participation in research (Cronbach’s alpha 0.82). Responses to items of these three components are given in Table 3.
Component 1: Support and opportunities to be involved in research
Respondents generally held positive views, with a median overall score of 70 (IQR 61–77), range possible 18–90 (midpoint 54), with 85 representing the highest possible positive score. The statements with the highest levels of disagreement were for the statements, ‘I have sufficient time to participate in research’ (disagree/strongly disagree 34.9%, n = 29) and ‘I have access to all of the resources (e.g. statistical advice, software) I need to be involved in research’ (disagree/strongly disagree 24.1%, n = 20).
Component 2: Motivation for and outcomes of involvement in research
Responses were very positive, with a median overall score of 33 (IQR 29–35), range possible 7–35 (midpoint 21), with 35 representing the highest possible positive score. The statements with the highest levels of agreement were for the statements, ‘Being involved in research is/would be of benefit to my profession’ (agree/strongly agree 98.8%, n = 82) and ‘I get/would get professional satisfaction from being involved in research’ (agree/strongly agree 95.1%, n = 79).
Component 3: Individual roles and characteristics around involvement in research
Respondents generally held very positive views, with a median overall score of 52 (IQR 47–56), range possible 12–60 (midpoint 36), with 60 representing the highest possible positive score. The most negative response was for ‘I feel anxious about being involved in research’ (agree/strongly agree 20.5%, n = 17).
Readiness to be involved in research
In response to questions on readiness to be involved in research: 1.2% (n = 1) had never thought about being involved in research; 6.0% (n = 5) had thought about being involved but had taken no action; 3.6% (n = 3) had thought about being involved and discussed with others; 7.2% (n = 6) had been involved in research in the past but had no plans to be involved in the future; 10.8% (n = 9) had been involved in research in the past and had plans to be involved in the future; and 71.1% (n = 59) were currently involved in research.
In terms of research training: 6.0% (n = 5) had never thought about research training; 14.5% (n = 12) had thought about research training but had taken no action; 16.9% (n = 14) had thought about research training and discussed with others; 6.0% (n = 5) had a plan for their research training; 6.0% (n = 5) had enrolled for research training; and 50.6% (n = 42) had undertaken research training.
Relating to the specific types of training: 9.6% (n = 8) were not interested in any training; 34.9% (n = 29) were interested in training but not leading to a formal university qualification; 16.9% (n = 14) were interested in university training at postgraduate certificate or postgraduate diploma levels; 4.8% (n = 4) were interested in university training at masters level; and 33.7% (n = 28) were interested in university training at doctoral level.
Content analysis of responses to open questions throughout the questionnaire identified several key themes. While many expressed a desire to be more involved in research generally, lack of resources such as time and funding were barriers,
Basically motivated, but at the moment I lack in time for proper research.
Dedicated time, time and time!
Funding is very limited for the research in my country.
Responses to how ESCP could support research involvement generated several themes, outlined in Table 4.
ESCP symposium discussion group
Thirteen ESCP members participated in the focus group held during the symposium, representing Turkey (n = 3), France (n = 2), Qatar (n = 2), Switzerland (n = 2), Croatia (n = 1), Nigeria (n = 1), Sweden (n = 1), UK (n = 1).
Research findings are presented under two main headings of barriers and expectations.
Barriers to research aspirations ESCP members
Barriers to the clinical pharmacy research aspirations of the participants were categorised into five key themes and associated subthemes, as shown in Table 5.
Expectations from ESCP
There were five key themes and associated subthemes for their expectations from ESCP, as shown in Table 6.
Discussion
ESCP member respondents were highly involved in research, interested, experienced and confident. Responses to all three PCA components were positive, with the most negative for items on sufficient time and access to resources. Participants of the qualitative phase identified a number of areas in which ESCP could support their research aspirations through mentoring, supporting collaboration, and providing education and training.
Strengths to this research include the mixed methods approach and the use of a framework of behaviour change theories. The major limitation is the response rate, which was disappointing given that the study population comprised members of a professional network. There are therefore potential issues resulting from response bias with those responding potentially more interested and involved in research. It is notable that in excess of 40% of respondents were from an academic setting and 70% possessed a Ph.D. Further limitations include the potential lack of validity of self-reported data and social desirability bias. The quantitative results may therefore lack generalisability and the qualitative findings transferability to all ESCP members and the population of pharmacists in Europe.
It is, however, clear that there is a cohort of highly research active ESCP members involved in leading, supervising, publishing and presenting research to a much higher extent than in previous studies [7, 8]. This finding is not surprising given the high proportion of academics within the study respondents, for whom there would be expectations of research activities. There is the potential to harness activities of these individuals to augment research capacity, aligned to the aim of ESCP. As an international organisation, there is an opportunity for ESCP to support multicentre research to optimise the impact on patients, practitioners, organisations and society.
The summary scores for research interest were significantly higher than for experience confidence, as has been found in other studies of pharmacists [7, 8] and other health professionals [18,19,20,21,22]. However, the actual scores for ESCP respondents were much higher than in other studies. For example, a recent study of pharmacists in Scotland gave median summary scores of 50, 38.5 and 42 using the same scales for interest, experience and confidence respectively compared to 68, 62 and 64 in this study [8]. Again, these differences are likely to be attributed to the differences in characteristics of the participants on the studies.
The scores for the three PCA items were also higher than for the same items in the study in Scotland [8]. For the ‘support and opportunities to be involved in research’, respondents were very positive in terms of their research environment, and the support from the organisation and others. These responses may also reflect the academic setting of many respondents. The most negative responses were around time and resources for research, which are similar findings to many other studies [7, 8]. These issues were also reflected in the themes identified from the content analysis of open comments and the discussion groups. The responses for the ‘motivation for and outcomes of involvement in research’ were particularly positive, with respondents in agreement with the impact of research on patients, practitioners, organisations and themselves. For the ‘individual roles and characteristics around involvement in research’, there were positive responses around items of confidence, competence and enthusiasm. There are therefore many enablers to ESCP members being involved in research.
TDF domains identified as barriers to research can be used to aid the development of behaviour change interventions, defined as ‘coordinated sets of activities designed to change specified behaviour patterns’ [23, 24]. These interventions consist of interacting components known as ‘behaviour change techniques’ (BCTs), which are ‘observable and replicable components designed to change behaviour’ [23, 24]. While the lowest scoring items of time and resources map to the TDF domain of ‘environmental context and resources’, the BCTs relate more to aspects of culture and require intervention at the organisational, leadership and management levels. Even though ESCP is not the employing organisation for the members, there is opportunity to have an influence, as identified in the qualitative element of the study.
Future research can centre around ESCP developing mechanisms to support these aspects followed by evaluation of quantitative (e.g. research activity and output) and qualitative (e.g. members’ perspectives) outcomes. In addition, there may be merit in focusing on those from non-academic settings.
Conclusion
ESCP participants in this study were highly research active, interested, experienced, confident and positive regarding research conduct and outcomes. There is an opportunity for ESCP to harness these activities, aligned to the ESCP aim, and provide support in the form of mentoring, education and training, and facilitating research collaboration.
References
Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10:608–22.
Hazen ACM, de Bont AA, Boelman L, Zwart DL, De Gier JJ, De Wit NJ, et al. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: a systematic review. Res Social Adm Pharm. 2018;14:228–40.
Stewart D, Jebara T, Cunningham S, Awaisu A, Pallivalapila A, MacLure K, et al. Future perspectives on nonmedical prescribing. Ther Adv Drug Saf. 2017;8:183–97.
Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev. 2016;11:CD011227.
Sackett DL, Rosenberg WM, Gray JM, Haynes RB, Richardson WS. Evidence based medicine. BMJ. 1996;313:170–1.
International Pharmaceutical Federation. https://www.fip.org/, Cited January 2020.
Awaisu A, Alsalimy N. Pharmacists’ involvement in and attitudes toward pharmacy practice research: a systematic review of the literature. Res Soc Adm Pharm. 2015;11:725–48.
Stewart D, Cunningham S, Strath A, MacLure A, Gibson-Smith K, Rushworth GF, et al. A theoretically informed survey of the views and experiences of practicing pharmacists on research conduct, dissemination and translation. Res Soc Adm Pharm. 2019;15:1298–308.
Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.
European Society of Clinical Pharmacy. https://www.escpweb.org/. Cited January 2020.
Department for International Development. Capacity building in research. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/187568/HTN_Capacity_Building_Final_21_06_10.pdf. Cited January 2020.
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;2:38.
Rogers EM. Diffusion of innovations. New York: Free Press; 2003 (ISBN 9780743222099).
Nakash RA, Hutton JL, Jorstad S, Gates S, Lamb SE. Maximising response to questionnaires—a systematic review of randomised trials in health research. BMC Med Res Methodol. 2006;6:5.
DeVellis RF. Scale development: theory and applications. New York: Sage; 1991 (ISBN 9781412980449).
Pallant J. SPSS survival manual. London: McGraw-Hill Education; 2013.
Elo S, Kääriäinen M, Kanste O, Pölkki T, Utriainen K, Kyngäs H. Qualitative content analysis: a focus on trustworthiness. Sage Open. 2014;4:1–10.
Harvey D, Plummer D, Pighills A, Pain T. Practitioner research capacity: a survey of social workers in Northern Queensland. Aust Soc Work. 2013;66:540–54.
Pager S, Holden L, Golenko X. Motivators, enablers, and barriers to building allied health research capacity. J Multidiscip Health. 2012;5:53–9.
Finch E, Cornwell P, Ward EC, McPhail SM. Factors influencing research engagement: research interest, confidence and experience in an Australian speechlanguage pathology workforce. BMC Health Serv Res. 2013;13:144.
Salmon P, Peters S, Rogers A, Gask L, Clifford R, Iredale W, et al. Peering through the barriers in GPs’ explanations for declining to participate in research: the role of professional autonomy and the economy of time. Fam Pract. 2007;24:269.
McMaster R, Jammali-Blasi A, Andersson-Noorgard K, Cooper K, McInnes E. Research involvement, support needs, and factors affecting research participation: a survey of Mental Health Consultation Liaison Nurses. Int J Ment Health Nurs. 2013;22:154–61.
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46:81–95.
Michie S, Wood CE, Johnston M, Abraham C, Francis J, Hardeman W, et al. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technol Assess. 2015;2015:19.
Acknowledgements
The publication of this article was funded by Qatar National Library. The authors are grateful to all ESCP members who completed the questionnaire and participated in the discussions, the International Office and Robert Gordon University, UK, for support with questionnaire online formatting.
Funding
Open access funding provided by Qatar National Library. No funding was obtained for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Stewart, D., Paudyal, V., Cadogan, C. et al. A survey of the European Society of Clinical Pharmacy members’ research involvement, and associated enablers and barriers. Int J Clin Pharm 42, 1073–1087 (2020). https://doi.org/10.1007/s11096-020-01054-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-020-01054-9